0,778  0,006  GST A substrate
0,760  0,004  Skin irritative effect
0,742  0,002  Acaricide
0,683  0,005  Histamine release inhibitor
0,683  0,007  Vasodilator, peripheral
0,684  0,009  Cholesterol antagonist
0,659  0,004  Anesthetic general
0,654  0,005  5 Hydroxytryptamine release inhibitor
0,653  0,005  Ulceration
0,649  0,004  FMO1 substrate
0,663  0,019  Teratogen
0,645  0,004  GABA C receptor rho-3 antagonist
0,636  0,003  Antiparkinsonian, rigidity relieving
0,645  0,014  Antihypercholesterolemic
0,643  0,012  Sensitization
0,642  0,019  Embryotoxic
0,597  0,012  Cardiovascular analeptic
0,595  0,009  Eye irritation, high
0,618  0,034  Caspase 9 stimulant
0,566  0,009  Vasodilator, coronary
0,571  0,015  Antipruritic, allergic
0,567  0,016  Spasmolytic
0,557  0,012  Calcium channel L-type activator
0,562  0,024  Aldehyde oxidase inhibitor
0,541  0,005  Anesthetic
0,534  0,024  Respiratory analeptic
0,511  0,009  Antihypoxic
0,498  0,010  Peroxidase inhibitor
0,492  0,004  Anesthetic local
0,499  0,018  Antihypertensive
0,485  0,004  Antiparkinsonian, tremor relieving
0,486  0,005  Skeletal muscle relaxant
0,504  0,027  5 Hydroxytryptamine release stimulant
0,477  0,008  Antiseptic
0,491  0,023  CTGF expression inhibitor
0,467  0,009  Flavin-containing monooxygenase substrate
0,482  0,025  Radioprotector
0,466  0,009  Calcium channel activator
0,462  0,009  Carcinogenic, group 3
0,462  0,018  Cardiodepressant
0,464  0,024  UGT1A9 substrate
0,442  0,004  Succinate dehydrogenase inhibitor
0,442  0,006  Antipruritic, non-allergic
0,447  0,011  Muscle relaxant
0,459  0,027  Analeptic
0,448  0,016  Vasodilator
0,448  0,018  UGT1A6 substrate
0,443  0,028  Carcinogenic
0,432  0,019  Radiosensitizer
0,433  0,022  Antipyretic
0,413  0,008  Alpha-N-acetylglucosaminidase inhibitor
0,442  0,042  Calpain 2 inhibitor
0,406  0,017  FMO3 substrate
0,403  0,014  5 Hydroxytryptamine uptake stimulant
0,392  0,003  Calcium antagonist
0,413  0,025  Antiglaucomic
0,428  0,043  Antithrombotic
0,411  0,028  UGT2B4 substrate
0,391  0,020  Interleukin agonist
0,397  0,027  Superoxide dismutase inhibitor
0,374  0,006  Gastrin inhibitor
0,376  0,011  Lipocortins synthesis antagonist
0,403  0,038  Lipoprotein disorders treatment
0,364  0,004  TRPA1 agonist
0,375  0,017  GST M1-1 substrate
0,378  0,032  Mutagenic
0,410  0,070  15-Lipoxygenase inhibitor
0,351  0,012  GST P1-1 substrate
0,348  0,010  Nav1.2 sodium channel blocker
0,346  0,008  Phospholipase A2 inhibitor
0,342  0,005  Adenylate kinase inhibitor
0,351  0,014  Phospholipase C inhibitor
0,399  0,063  Immunosuppressant
0,358  0,024  Cyclic AMP phosphodiesterase inhibitor
0,364  0,032  Hypolipemic
0,373  0,044  Lipoxygenase inhibitor
0,394  0,065  CYP2C9 substrate
0,338  0,010  CNS active muscle relaxant
0,351  0,031  Psychostimulant
0,341  0,021  Antimutagenic
0,324  0,005  GABA C receptor rho-2 antagonist
0,376  0,057  Immunostimulant
0,323  0,004  Photosensitizer
0,336  0,019  Tyrosine 3 hydroxylase inhibitor
0,363  0,050  Antiischemic
0,319  0,008  Nav1.3 sodium channel blocker
0,379  0,068  Transcription factor NF kappa B inhibitor
0,391  0,081  TNF expression inhibitor
0,315  0,009  Carcinogenic, group 1
0,355  0,049  CYP2C19 substrate
0,315  0,010  Antihyperlipoproteinemic
0,317  0,018  Hair growth stimulant
0,367  0,067  Thyroid hormone antagonist
0,326  0,030  Abortion inducer
0,335  0,042  Platelet antagonist
0,396  0,104  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,309  0,021  Pneumotoxic
0,293  0,006  Cyclooxygenase 3 inhibitor
0,286  0,005  Toll-Like receptor 2 antagonist
0,288  0,009  Nav1.1 sodium channel blocker
0,307  0,031  Sedative
0,314  0,039  Antiulcerative
0,344  0,071  Thyroid hormone beta antagonist
0,301  0,030  Myocardial ischemia treatment
0,301  0,033  Platelet adhesion inhibitor
0,281  0,014  Renal failure treatment
0,290  0,023  Antiacne
0,287  0,021  Antihelmintic (Nematodes)
0,343  0,081  CYP3A4 substrate
0,281  0,020  Protein kinase stimulant
0,281  0,021  Insulin sensitizer
0,313  0,053  NOS2 expression inhibitor
0,264  0,005  GABA C receptor antagonist
0,274  0,014  Aldehyde dehydrogenase inhibitor
0,290  0,030  Non-steroidal antiinflammatory agent
0,268  0,011  Ferrochelatase inhibitor
0,258  0,006  Raynaud's phenomenon treatment
0,283  0,031  VCAM1 expression inhibitor
0,267  0,017  Glutathione S-transferase substrate
0,282  0,037  UGT1A1 substrate
0,252  0,010  Alcohol dehydrogenase substrate
0,255  0,017  Antifungal enhancer
0,327  0,089  Stroke treatment
0,263  0,026  Cytidine deaminase inhibitor
0,270  0,034  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,273  0,039  RNA-directed DNA polymerase inhibitor
0,239  0,005  Sphingosine 1-phosphate receptor 4 antagonist
0,287  0,055  Cytostatic
0,237  0,005  GABA C receptor rho-1 antagonist
0,280  0,049  Antiparasitic
0,272  0,043  Platelet aggregation inhibitor
0,308  0,080  Apoptosis antagonist
0,237  0,009  Arachidonic acid antagonist
0,241  0,014  Excitatory amino acid transporter EAAC1 inhibitor
0,245  0,018  Calcium channel blocker
0,231  0,004  GST T1-1 substrate
0,228  0,004  Ornithine decarboxylase inhibitor
0,277  0,052  DNA synthesis inhibitor
0,237  0,014  Carbonic anhydrase XV inhibitor
0,233  0,010  Catalase inhibitor
0,301  0,078  Sodium/bile acid cotransporter inhibitor
0,282  0,060  Hypoglycemic
0,226  0,006  Keratolytic
0,315  0,095  Prostaglandin dehydrogenase inhibitor
0,304  0,087  ICAM1 expression inhibitor
0,276  0,060  Vascular (periferal) disease treatment
0,262  0,047  Antihypotensive
0,234  0,018  UGT2B10 substrate
0,294  0,079  Antipsoriatic
0,232  0,018  Phobic disorders treatment
0,288  0,074  CYP1A2 substrate
0,237  0,024  Toxic, respiratory center
0,219  0,007  Actinic keratosis treatment
0,241  0,030  Interferon gamma antagonist
0,215  0,004  Potassium channel intermediate-conductance Ca-activated blocker
0,235  0,025  Genotoxic
0,280  0,072  Insulysin inhibitor
0,218  0,010  Aldehyde dehydrogenase substrate
0,226  0,018  Neurotrophic factor
0,225  0,017  Antirickettsial
0,345  0,140  DNA directed DNA polymerase inhibitor
0,213  0,007  Sphingosine 1-phosphate receptor 5 antagonist
0,219  0,014  Nav1.6 sodium channel blocker
0,253  0,048  Wound healing agent
0,234  0,030  Acetylcholine M1 receptor antagonist
0,272  0,070  DNA damaging
0,248  0,046  Antialcoholic
0,287  0,086  Antifungal
0,255  0,054  Antihypertriglyceridemic
0,206  0,006  Sphingosine 1-phosphate receptor 2 antagonist
0,226  0,027  VEGF expression inhibitor
0,244  0,047  Antihelmintic
0,256  0,059  Calpain inhibitor
0,312  0,116  CYP2C19 inhibitor
0,239  0,043  CYP2B6 inhibitor
0,240  0,044  Antianginal
0,222  0,028  Pancreatic disorders treatment
0,284  0,090  CYP2D6 substrate
0,218  0,025  ATPase inhibitor
0,195  0,004  Ca2+-transporting ATPase inhibitor
0,314  0,125  Antibacterial
0,215  0,026  Cocaine dependence treatment
0,197  0,010  Sphingomyelinase inhibitor
0,218  0,031  UGT2B9 substrate
0,204  0,019  CF transmembrane conductance regulator agonist
0,186  0,003  Granulocyte macrophage colony stimulating factor agonist
0,199  0,017  Choleretic
0,212  0,030  Monophenol monooxygenase inhibitor
0,186  0,006  Calcium channel L-type blocker
0,230  0,050  UGT2B7 substrate
0,191  0,012  Antiviral (Influenza B)
0,186  0,007  Alcohol oxidase inhibitor
0,195  0,017  UGT2B1 substrate
0,188  0,010  Electrolyte absorption antagonist
0,190  0,012  Creatine kinase inhibitor
0,248  0,071  Angiogenesis stimulant
0,183  0,006  Paget's disease treatment
0,182  0,005  Acetylcholine release stimulant
0,188  0,012  Triose-phosphate isomerase inhibitor
0,190  0,015  Vanilloid 1 agonist
0,328  0,153  Apoptosis agonist
0,182  0,007  Glutathione S-transferase inhibitor
0,232  0,058  Antiviral (West Nile virus)
0,177  0,003  Glutamate (mGluR6) antagonist
0,183  0,010  Heat shock protein 70 antagonist
0,190  0,018  Coagulant
0,177  0,005  Glutamate release inhibitor
0,200  0,030  SULT1A3 substrate
0,251  0,082  Cardiotonic
0,187  0,017  Mediator release inhibitor
0,209  0,041  Amylase inhibitor
0,225  0,058  UDP-glucuronosyltransferase substrate
0,178  0,010  Toll-Like receptor 4 antagonist
0,224  0,056  Neurotrophic factor enhancer
0,211  0,045  UGT1A3 substrate
0,261  0,096  NOS3 expression inhibitor
0,169  0,004  Endocannabinoid uptake inhibitor
0,169  0,004  Antiviral (Parainfluenza)
0,170  0,008  Antiviral (Rhinovirus)
0,204  0,042  Muscular dystrophy treatment
0,228  0,068  Cytotoxic
0,184  0,025  Antiviral (Poxvirus)
0,211  0,053  UGT1A4 substrate
0,218  0,060  DNA methyltransferase I inhibitor
0,165  0,008  Acyl-CoA dehydrogenase inhibitor
0,179  0,021  UDP-glucose 4-epimerase inhibitor
0,159  0,004  Aconitate hydratase inhibitor
0,201  0,046  Protein-tyrosine phosphatase inhibitor
0,272  0,117  Antineoplastic (endocrine cancer)
0,172  0,018  Gastric antisecretory
0,182  0,028  Antiprotozoal (Trichomonas)
0,162  0,009  Interferon agonist
0,178  0,025  Xanthine oxidase inhibitor
0,179  0,027  Antineoplastic antimetabolite
0,177  0,025  GABA C receptor agonist
0,155  0,005  Purinergic P2Y antagonist
0,187  0,038  Antiprotozoal (Coccidial)
0,179  0,030  Farnesoid X receptor antagonist
0,192  0,043  Antidote
0,170  0,022  Mucolytic
0,157  0,009  Lanosterol 14 alpha demethylase inhibitor
0,246  0,099  Cardioprotectant
0,175  0,028  Aminopeptidase B inhibitor
0,190  0,043  Thiol protease inhibitor
0,203  0,057  5 Hydroxytryptamine 3E antagonist
0,247  0,101  Antiepileptic
0,160  0,014  Antifungal (Pneumocystis)
0,159  0,014  Anabolic
0,178  0,033  Cholesterol synthesis inhibitor
0,233  0,089  Proliferative diseases treatment
0,160  0,016  Phosphofructokinase-1 inhibitor
0,189  0,046  Melanin inhibitor
0,151  0,007  Protein kinase C eta inhibitor
0,151  0,008  Sphingosine 1-phosphate receptor 4 agonist
0,178  0,036  DNA polymerase I inhibitor
0,200  0,060  Antiviral (Ebola)
0,173  0,034  Antitussive
0,201  0,061  Sigma receptor agonist
0,167  0,028  SULT1A1 substrate
0,163  0,024  Carbonic anhydrase III inhibitor
0,226  0,087  Antineoplastic (liver cancer)
0,248  0,110  12-Lipoxygenase inhibitor
0,142  0,004  Squalene epoxidase inhibitor
0,171  0,033  Antibacterial (Helicobacter pylori)
0,149  0,011  Dyspepsia treatment
0,144  0,008  Hyperparathyroidism treatment
0,139  0,004  Nicotinic alpha3beta2 receptor antagonist
0,276  0,141  Atherosclerosis treatment
0,145  0,010  Leukotriene synthesis inhibitor
0,159  0,026  Antineoplastic, alkylator
0,182  0,050  Uterine stimulant
0,204  0,072  Antiviral (Influenza)
0,166  0,036  Cathepsin H inhibitor
0,158  0,027  Protein kinase C gamma inhibitor
0,150  0,022  Carbonic anhydrase XIII inhibitor
0,155  0,027  Antiviral (Papilloma)
0,132  0,005  GABA B receptor agonist
0,131  0,005  Sphingosine 1-phosphate receptor 3 antagonist
0,173  0,047  Mannose-6-phosphate isomerase inhibitor
0,193  0,067  Chemopreventive
0,135  0,009  Glycine receptor agonist
0,143  0,017  Macrophage migration inhibitory factor inhibitor
0,194  0,069  Hepatoprotectant
0,157  0,032  Expectorant
0,129  0,004  Lysophosphatidic acid 2 receptor antagonist
0,165  0,041  Adenylate cyclase stimulant
0,147  0,023  Antispirochetal
0,127  0,005  Potassium channel Kv1.3 blocker
0,163  0,041  Protein-tyrosine phosphatase 1B inhibitor
0,126  0,004  Glutamate (mGluR1a) antagonist
0,215  0,094  Heart failure treatment
0,138  0,017  Interleukin 12 antagonist
0,183  0,062  Antipruritic
0,175  0,054  Antiischemic, cerebral
0,215  0,095  Neuropeptide Y2 antagonist
0,129  0,009  CDC25B inhibitor
0,243  0,123  AR expression inhibitor
0,126  0,006  Oleamide hydrolase inhibitor
0,126  0,006  Interferon inducer
0,131  0,012  Toll-Like receptor 2 agonist
0,154  0,036  5-Lipoxygenase inhibitor
0,200  0,083  Anticonvulsant
0,224  0,108  Chemoprotective
0,143  0,029  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,125  0,011  Antidote, heavy metal
0,170  0,056  Lipid peroxidase inhibitor
0,119  0,005  Dihydroorotase inhibitor
0,162  0,048  Hearing loss treatment
0,176  0,063  Aldehyde oxidase substrate
0,183  0,070  Amyloid beta precursor protein antagonist
0,216  0,104  Antioxidant
0,127  0,014  Leukotriene antagonist
0,145  0,032  Caspase 3 inhibitor
0,136  0,024  Carbonic anhydrase VI inhibitor
0,183  0,071  Dual specificity phosphatase 3 inhibitor
0,121  0,009  Estrogen-related receptor beta agonist
0,128  0,017  CDC25A inhibitor
0,162  0,050  Movement disorders treatment
0,155  0,044  Alkylator
0,170  0,059  Antiviral (Influenza A)
0,125  0,014  Argininosuccinate synthase inhibitor
0,134  0,024  UGT2B11 substrate
0,114  0,004  Anesthetic inhalation
0,114  0,004  Lysophosphatidic acid 3 receptor antagonist
0,146  0,036  Shock treatment
0,145  0,036  Calcium channel (voltage-sensitive) blocker
0,193  0,084  DNA methylase inhibitor
0,170  0,062  Neurotensin receptor agonist
0,133  0,026  Interleukin 1 beta converting enzyme inhibitor
0,135  0,029  Prolactin inhibitor
0,136  0,030  DOPA decarboxylase inhibitor
0,149  0,044  Acetylcholine muscarinic antagonist
0,155  0,050  Cholinergic antagonist
0,121  0,017  Acetylcholine M4 receptor antagonist
0,152  0,048  Interleukin 4 antagonist
0,170  0,066  Prostate disorders treatment
0,160  0,057  Hemostatic
0,197  0,094  Nitric-oxide synthase stimulant
0,154  0,050  Antieczematic
0,109  0,005  Alpha-mannosidase inhibitor
0,155  0,052  Toll-Like receptor antagonist
0,157  0,054  Bone formation stimulant
0,120  0,017  Nicotinic alpha4beta2 receptor antagonist
0,181  0,079  P-glycoprotein inhibitor
0,128  0,026  Porphobilinogen synthase inhibitor
0,131  0,029  Carcinogenic, group 2A
0,114  0,012  Beta adrenoreceptor antagonist
0,147  0,045  Antiprotozoal (Amoeba)
0,107  0,006  Nitric oxide donor
0,167  0,067  Cystic fibrosis treatment
0,109  0,009  Leukocyte elastase inhibitor
0,119  0,019  Glycine receptor antagonist
0,116  0,016  Antiviral (Hepatitis A)
0,104  0,004  Cholesterol esterase inhibitor
0,161  0,062  UGT2B15 substrate
0,126  0,028  Acetylcholine nicotinic antagonist
0,132  0,034  Electron transport complex I inhibitor
0,148  0,051  Acetylcholine antagonist
0,234  0,137  Interleukin 2 agonist
0,124  0,027  Tourette's syndrome treatment
0,212  0,117  5 Hydroxytryptamine 1E antagonist
0,170  0,075  3C-like protease (Human coronavirus) inhibitor
0,138  0,043  GABA receptor agonist
0,270  0,176  Alpha-glucosidase inhibitor
0,155  0,061  Cell wall synthesis inhibitor
0,105  0,012  Transcription factor AP-1 inhibitor
0,105  0,012  Antidote, organophosphates
0,119  0,026  Adrenaline agonist
0,118  0,025  Interleukin 5 antagonist
0,109  0,016  Biliverdin reductase inhibitor
0,106  0,015  Neuraminidase (influenza) inhibitor
0,120  0,028  NADH dehydrogenase inhibitor
0,109  0,017  Sphingosine 1-phosphate receptor antagonist
0,121  0,030  Thioredoxin inhibitor
0,136  0,046  Microtubule formation inhibitor
0,211  0,120  Transcription factor STAT3 inhibitor
0,103  0,014  Neuraminidase inhibitor
0,114  0,025  Bile acid receptor antagonist
0,119  0,030  Toll-Like receptor 3 antagonist
0,122  0,033  Alcohol dehydrogenase inhibitor
0,123  0,035  Protein kinase C delta inhibitor
0,092  0,004  Purinergic P2Y12 antagonist
0,109  0,021  GABA aminotransferase inhibitor
0,117  0,030  Antidote, mercury
0,151  0,064  Neuropeptide Y1 antagonist
0,093  0,006  Mannosidase inhibitor
0,099  0,012  Peroxisome proliferator-activated receptor alpha agonist
0,100  0,013  Acetyl-CoA transferase inhibitor
0,176  0,090  Septic shock treatment
0,109  0,023  Peroxisome proliferator-activated receptor gamma agonist
0,160  0,074  Thrombolytic
0,110  0,025  Glutamate decarboxylase inhibitor
0,126  0,041  Sulfotransferase substrate
0,090  0,006  Retinoid X receptor agonist
0,156  0,072  Diuretic
0,196  0,112  Myocardial infarction treatment
0,092  0,009  5 Hydroxytryptamine 4 antagonist
0,090  0,007  Adenosine deaminase inhibitor
0,099  0,016  Ornithine carbamoyltransferase inhibitor
0,099  0,016  Peroxisome proliferator-activated receptor gamma antagonist
0,112  0,029  Cathepsin G inhibitor
0,105  0,022  Epoxide hydrolase inhibitor
0,094  0,012  Leukotriene B4 antagonist
0,129  0,048  Falcipain 3 inhibitor
0,092  0,010  Sphingosine kinase 2 inhibitor
0,123  0,042  Antiprotozoal (Toxoplasma)
0,085  0,004  Angiotensin II receptor antagonist
0,103  0,023  Amidase inhibitor
0,264  0,184  DNA polymerase beta inhibitor
0,108  0,027  Glutamate dehydrogenase inhibitor
0,085  0,005  Glutamate (mGluR3) antagonist
0,090  0,011  Sphingosine kinase inhibitor
0,088  0,009  Thromboxane synthase inhibitor
0,093  0,015  Gaucher disease treatment
0,093  0,015  Antimycoplasmal
0,098  0,020  NMDA receptor agonist
0,153  0,077  Neuropathy treatment
0,088  0,012  Glucosylceramidase inhibitor
0,102  0,026  Adenosine A3 receptor antagonist
0,115  0,039  Antifungal (Aspergillus)
0,081  0,006  Nicotinic acid receptor agonist
0,090  0,015  Exportin-1 inhibitor
0,191  0,117  Acute neurologic disorders treatment
0,166  0,093  Antiviral (Hepatitis)
0,132  0,058  Gastritis treatment
0,078  0,005  Benzodiazepine antagonist
0,081  0,008  Glucose-6-phosphate isomerase inhibitor
0,100  0,028  Caspase 7 inhibitor
0,158  0,086  Dual specificity phosphatase inhibitor
0,100  0,028  Aminopeptidase I inhibitor
0,099  0,027  Antiviral (Dengue virus)
0,115  0,043  Folate antagonist
0,080  0,008  Leukotriene C antagonist
0,236  0,164  Beta lactamase inhibitor
0,130  0,058  Growth stimulant
0,107  0,036  Restless leg syndrome treatment
0,091  0,021  S-adenosyl-L-methionine decarboxylase inhibitor
0,092  0,022  Anticholelithogenic
0,076  0,005  GABA uptake inhibitor
0,134  0,064  Retinoprotector
0,073  0,004  Angiotensin AT1 receptor antagonist
0,217  0,148  Antiallergic
0,181  0,113  Free radical scavenger
0,092  0,023  Carbamoyl phosphate synthetase inhibitor
0,084  0,016  Dihydroorotate dehydrogenase inhibitor
0,076  0,008  Glutamate (mGluR group III) antagonist
0,088  0,021  Acetylcholine M5 receptor antagonist
0,146  0,080  Ca2+/calmodulin-dependent protein kinase kinase B inhibitor
0,084  0,018  Thromboxane antagonist
0,087  0,021  Potassium channel (Tandem pore domain) blocker
0,091  0,025  Acetylcholine M5 receptor agonist
0,096  0,031  NAT1 substrate
0,106  0,041  Phosphodiesterase 6D inhibitor
0,074  0,008  Retinoid X alpha receptor agonist
0,072  0,006  Cytokine production stimulant
0,114  0,049  Bronchodilator
0,080  0,015  Calcium channel P-type blocker
0,101  0,038  Transcription factor NF kappa B stimulant
0,080  0,017  Carbonic anhydrase XIV inhibitor
0,086  0,022  TRPA1 antagonist
0,146  0,082  Restenosis treatment
0,098  0,036  Histamine H2 receptor antagonist
0,069  0,007  Angiotensin AT2 receptor antagonist
0,104  0,043  Histamine N-methyltransferase inhibitor
0,077  0,016  Thromboxane A2 antagonist
0,138  0,078  Pregnane X receptor agonist
0,088  0,028  Elastase 1 inhibitor
0,063  0,003  Lysophosphatidic acid receptor 1 agonist
0,068  0,009  GABA B receptor antagonist
0,118  0,059  Sphingosine 1-phosphate receptor 2 agonist
0,237  0,179  CYP2C9 inhibitor
0,075  0,016  Sphingosine 1-phosphate receptor 1 antagonist
0,081  0,023  Androgen agonist
0,083  0,026  Protein kinase C beta inhibitor
0,077  0,020  Beta 1 adrenoreceptor antagonist
0,082  0,025  Glutamate (mGluR7) antagonist
0,079  0,023  Carbonic anhydrase VB inhibitor
0,128  0,072  Antihelmintic (Trematoda)
0,133  0,077  Cytokine production inhibitor
0,070  0,015  Adenine nucleotide translocase inhibitor
0,152  0,098  Tumour necrosis factor antagonist
0,126  0,072  M17 leucyl aminopeptidase inhibitor
0,069  0,015  Pregnane X receptor antagonist
0,111  0,057  HDL-cholesterol increasing
0,088  0,034  Prostaglandin-E synthase inhibitor
0,135  0,082  Antianorexic
0,060  0,006  Retinoid X receptor antagonist
0,080  0,027  Protease 3C (Human rhinovirus) inhibitor
0,115  0,062  Cystathionine beta-synthase inhibitor
0,110  0,058  AMP-activated protein kinase stimulant
0,082  0,031  Phospholipase D inhibitor
0,080  0,029  NMDA receptor glycine site agonist
0,068  0,018  Beta 2 adrenoreceptor antagonist
0,078  0,027  Narcolepsy treatment
0,101  0,050  Antifungal (Candida)
0,057  0,006  Uridine phosphorylase inhibitor
0,113  0,063  Myasthenia Gravis treatment
0,061  0,011  Guanylate cyclase inhibitor
0,074  0,024  GABA A receptor antagonist
0,064  0,014  Kainate receptor antagonist
0,061  0,011  Kainate receptor 2 antagonist
0,058  0,009  Purinergic P2T antagonist
0,076  0,027  Purinergic P2X1 antagonist
0,073  0,024  GABA receptor antagonist
0,092  0,043  mTOR complex 2 inhibitor
0,067  0,018  Antiviral (Herpesvirus 3, Human)
0,083  0,035  Phenylalanine 4-hydroxylase inhibitor
0,099  0,051  ABCA1 expression enhancer
0,053  0,005  Glutamate (mGluR1) agonist
0,120  0,072  Antiviral (Hepatitis B)
0,055  0,007  Free fatty acid receptor 1 antagonist
0,073  0,025  Phosphodiesterase 1C inhibitor
0,050  0,002  Lysophosphatidic acid receptor 3 agonist
0,052  0,005  Glutamate (mGluR3) agonist
0,116  0,069  Proteasome inhibitor
0,054  0,007  Liver X receptor beta antagonist
0,057  0,011  Acetyl-CoA transferase 1 inhibitor
0,115  0,069  Antiprotozoal (Babesia)
0,067  0,020  Acetyl-CoA transferase 2 inhibitor
0,054  0,008  Leukotriene C4 antagonist
0,050  0,004  Calcium-independent phospholipase A2 inhibitor
0,051  0,005  Retinoid X alpha receptor antagonist
0,082  0,037  Vanilloid 4 agonist
0,088  0,043  Na+ K+ transporting ATPase inhibitor
0,057  0,011  Farnesoid X receptor agonist
0,107  0,062  Carcinogenic, group 2B
0,055  0,011  Retinoic acid alpha receptor agonist
0,063  0,019  Heparanase inhibitor
0,049  0,005  Retinoic acid receptor agonist
0,051  0,007  Melatonin receptor 1A agonist
0,123  0,081  Skin whitener
0,052  0,010  Glutamate (mGluR8) agonist
0,054  0,012  Fumarate hydratase inhibitor
0,135  0,093  Acute respiratory distress syndrome (ARDS) treatment
0,050  0,009  1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor
0,044  0,003  Carbonic anhydrase VIII inhibitor
0,044  0,003  Carbonic anhydrase X inhibitor
0,074  0,033  Acetylcholine M2 receptor antagonist
0,072  0,031  Beta 3 adrenoreceptor antagonist
0,071  0,030  Xanthine dehydrogenase inhibitor
0,083  0,043  Narcotic antagonist
0,078  0,038  Selectin antagonist
0,053  0,013  Beta adrenoreceptor agonist
0,060  0,021  CD45 antagonist
0,066  0,027  Beta 2 adrenoreceptor agonist
0,054  0,015  Dihydropteroate synthase inhibitor
0,056  0,017  Neuraminidase (Influenza A) inhibitor
0,044  0,005  Protein kinase C beta I inhibitor
0,067  0,028  Phosphodiesterase 1A inhibitor
0,052  0,014  Membrane dipeptidase inhibitor
0,055  0,016  Glutamate (mGluR4) antagonist
0,116  0,078  Contraceptive female
0,101  0,063  Chronic obstructive bronchitis treatment
0,086  0,048  Glutamate receptor agonist
0,085  0,047  NAD(P)H dehydrogenase (quinone) inhibitor
0,051  0,013  Kainate receptor agonist
0,052  0,014  Sphingosine kinase 1 inhibitor
0,044  0,007  Prostaglandin EP2 agonist
0,080  0,043  Histidine decarboxylase inhibitor
0,048  0,011  Sodium-dependent vitamin C transporter 2 inhibitor
0,054  0,017  5-Alpha-reductase inhibitor
0,057  0,021  Nicotinic receptor alpha3 subunit antagonist
0,045  0,009  Leukotriene B4 receptor 1 antagonist
0,049  0,012  Delayed rectifier potassium channel blocker
0,063  0,027  Elastase inhibitor
0,069  0,033  Prostaglandin EP2 antagonist
0,073  0,037  SULT2A1 substrate
0,040  0,005  Nicotinic acid receptor 2 antagonist
0,104  0,069  Antihelmintic (Fasciola)
0,105  0,070  Chelator
0,081  0,047  Estrogen receptor alpha antagonist
0,042  0,008  Elastase 2B inhibitor
0,042  0,008  Elastase 3A inhibitor
0,042  0,008  Elastase 3B inhibitor
0,044  0,012  Prostaglandin agonist
0,042  0,009  Protein kinase C beta II inhibitor
0,070  0,037  Antiemphysemic
0,054  0,022  Sphingosine 1-phosphate receptor agonist
0,070  0,038  MDM2 inhibitor
0,049  0,016  3-Hydroxyanthranilate 3,4-dioxygenase inhibitor
0,051  0,019  Sphingosine 1-phosphate receptor 1 agonist
0,077  0,046  Phosphodiesterase VI inhibitor
0,052  0,020  Geranyltranstransferase inhibitor
0,044  0,012  Ceramide glucosyltransferase inhibitor
0,035  0,005  Retinoic acid beta receptor agonist
0,036  0,005  Acid ceramidase inhibitor
0,108  0,077  Adenylate cyclase inhibitor
0,093  0,062  HIV-1 integrase (Overall Integration) inhibitor
0,065  0,035  Acetylcholine M3 receptor antagonist
0,115  0,085  Antismoking
0,036  0,006  Glutamate (mGluR1a) agonist
0,034  0,004  Neuraminidase (Influenza B) inhibitor
0,040  0,011  Epoxide hydrolase 1 inhibitor
0,138  0,109  Antiviral (Hepatitis C)
0,149  0,120  Sepsis treatment
0,056  0,028  Antimetabolite
0,070  0,041  Potassium channel (ATP-sensitive) blocker
0,064  0,035  Dopamine uptake inhibitor
0,061  0,033  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,032  0,004  Angiotensin AT1B receptor antagonist
0,049  0,020  Dihydrofolate reductase inhibitor
0,035  0,007  Prostaglandin F2 alpha agonist
0,034  0,006  Vanilloid 2 agonist
0,108  0,080  Estrogen antagonist
0,044  0,016  Squalene synthetase inhibitor
0,229  0,202  Transcription factor inhibitor
0,051  0,023  Antiviral (Enterovirus)
0,051  0,024  Fructose-1,6-bisphosphatase inhibitor
0,145  0,118  Catenin beta inhibitor
0,092  0,065  Antischistosomal
0,035  0,008  Estrogen-related receptor gamma antagonist
0,037  0,010  Peroxisome proliferator-activated receptor alpha antagonist
0,084  0,058  Vanilloid agonist
0,077  0,051  SULT1A2 substrate
0,070  0,045  Neuronal nicotinic receptor antagonist
0,047  0,022  Liver X receptor alpha agonist
0,057  0,032  Immunoglobulin Fc receptor antagonist
0,033  0,008  Glucosylceramidase stimulant
0,031  0,006  Lysophosphatidic acid 1 receptor antagonist
0,039  0,014  GABA transporter 3 inhibitor
0,033  0,008  Hedgehog signaling activator
0,030  0,005  Isoleucine-tRNA ligase inhibitor
0,042  0,018  Vanilloid 3 antagonist
0,107  0,082  Interleukin 8 antagonist
0,033  0,010  DNA polymerase III inhibitor
0,060  0,037  Lipocortins synthesis agonist
0,051  0,028  Aldosterone antagonist
0,069  0,046  Protein kinase C alpha inhibitor
0,027  0,005  Retinoid X beta receptor antagonist
0,096  0,073  Gout treatment
0,039  0,017  Carnitine palmitoyltransferase inhibitor
0,094  0,073  Glutamate (mGluR7) agonist
0,039  0,018  Peroxisome proliferator-activated receptor delta agonist
0,038  0,017  Liver X receptor beta agonist
0,035  0,013  Leukotriene D4 antagonist
0,028  0,007  Angiotensin AT1A receptor antagonist
0,094  0,073  Urease inhibitor
0,105  0,084  Menstruation disorders treatment
0,051  0,032  Bombesin 2 receptor antagonist
0,037  0,018  Benzodiazepine receptor peripheral-type antagonist
0,077  0,058  Chymotrypsin inhibitor
0,133  0,114  Nitric oxide antagonist
0,025  0,007  Toll-Like receptor 8 agonist
0,099  0,080  Antihypermotility
0,031  0,013  Calcium-sensing receptor agonist
0,022  0,005  Granulocyte colony stimulating factor receptor agonist
0,081  0,064  D-Ala-D-Ala ligase inhibitor
0,051  0,034  Prolyl endopeptidase inhibitor
0,081  0,064  Androgen antagonist
0,034  0,018  Cholesterol ester transfer protein antagonist
0,065  0,048  Carbonic anhydrase V inhibitor
0,087  0,070  Uric acid excretion stimulant
0,080  0,064  GABA A receptor agonist
0,026  0,011  Leukotriene B4 receptor 2 antagonist
0,025  0,010  Retinoid X beta receptor agonist
0,038  0,023  Nicotinic acid receptor 2 agonist
0,025  0,010  5-Alpha-reductase 1 inhibitor
0,095  0,080  Antiinfertility, female
0,049  0,034  Plasminogen activator inhibitor antagonist
0,041  0,026  Dopamine D5 agonist
0,053  0,038  Ribonucleoside-diphosphate reductase inhibitor
0,113  0,099  Interleukin 1 antagonist
0,046  0,032  Carbonic anhydrase VII inhibitor
0,058  0,044  Ryanodine receptor antagonist
0,053  0,040  Ribonucleotide reductase inhibitor
0,035  0,022  Calcitonin receptor agonist
0,032  0,019  Prostaglandin D2 agonist
0,053  0,040  Sphingosine 1-phosphate receptor 5 agonist
0,075  0,063  Histamine H1 receptor antagonist
0,026  0,014  Prostaglandin E2 agonist
0,049  0,037  Diacylglycerol O-acyltransferase inhibitor
0,017  0,005  Carbonic anhydrase XI inhibitor
0,020  0,009  G-protein-coupled receptor 120 agonist
0,023  0,012  GABA transporter inhibitor
0,015  0,004  Angiotensin AT2 receptor agonist
0,032  0,022  ATP citrate lysase inhibitor
0,182  0,172  Bone diseases treatment
0,022  0,012  5-Alpha-reductase 2 inhibitor
0,034  0,024  Carnitine palmitoyltransferase 1 inhibitor
0,109  0,099  NADPH oxidase inhibitor
0,025  0,015  5 Hydroxytryptamine 4 agonist
0,027  0,017  Prostaglandin EP4 antagonist
0,036  0,027  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,054  0,044  Glutamate (mGluR1) antagonist
0,037  0,028  Glutamate (mGluR group II) antagonist
0,029  0,020  Liver X receptor alpha antagonist
0,037  0,028  NMDA receptor subunit 3A antagonist
0,023  0,014  Kainate receptor 1 antagonist
0,019  0,010  Ileal bile acid transport inhibitor
0,032  0,023  Methionyl aminopeptidase 1 inhibitor
0,084  0,076  Protein kinase C zeta inhibitor
0,018  0,010  Vesicular glutamate transport inhibitor
0,050  0,042  Vanilloid 2 antagonist
0,054  0,047  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,063  0,056  Carbonic anhydrase VA inhibitor
0,014  0,007  Calcium-dependent phospholipase A2 inhibitor
0,137  0,131  LDLR expression enhancer
0,018  0,012  Methylmalonyl-CoA mutase inhibitor
0,016  0,010  GABA transporter 1 inhibitor
0,019  0,014  Caspase 8 inhibitor
0,017  0,011  Vitamin D receptor agonist
0,028  0,023  Acetylcholine M4 receptor agonist
0,065  0,060  Lipase inhibitor
0,012  0,007  Thromboxane agonist
0,016  0,011  Thromboxane A2 agonist
0,033  0,028  Arginase inhibitor
0,018  0,013  Estrogen-related receptor gamma agonist
0,022  0,017  Beta 1 adrenoreceptor agonist
0,022  0,017  Retinoid X gamma receptor agonist
0,038  0,034  Oxytocin agonist
0,041  0,037  Heme oxygenase inhibitor
0,025  0,022  Thymidine kinase (Herpes simplex virus 1) inhibitor
0,048  0,045  Acetylcholine muscarinic agonist
0,151  0,148  MAP kinase kinase 5 inhibitor
0,037  0,035  Thymidine kinase inhibitor
0,180  0,178  Hypoxia-inducible factor 1 alpha inhibitor
0,031  0,029  Phosphoglycerate kinase inhibitor
0,051  0,049  Fatty acid synthase inhibitor
0,058  0,056  Histone deacetylase SIRT3 inhibitor
0,031  0,029  Glutamate (mGluR group II) agonist
0,014  0,013  Purinergic P2Y1 agonist
0,152  0,151  Antineoplastic enhancer
0,101  0,100  Mental retardation treatment
0,012  0,011  1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor
0,013  0,011  Cyclin D2 inhibitor
0,053  0,053  Phosphodiesterase 1B inhibitor
0,044  0,044  NMDA 2A receptor antagonist
0,134  0,134  Antiarrhythmic
0,027  0,026  Glutamate (mGluR2) antagonist
0,028  0,028  Sirtuin 2 inhibitor

